Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THR-18 single-dose escalation with placebo in acute ischemic stroke patients treated with tPA
2011-005317-37Phase 2Active
- Sponsor
- Thrombotech Ltd.
- Start
- Jan 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of THR-18 in ischemic stroke (4 arms), sponsored by Thrombotech Ltd. Primary endpoints: Safety of THR-18 and Pharmacokinetic profile of THR-18. Started Jan 2012; status: active.
02
Drugs
THR-18
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2011-005317-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005317-37.